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Abstract
Nerve preservation is an important issue during most surgery because accidental transection or
injury results in significant morbidity, including numbness, pain, weakness, or paralysis. Currently,
nerves are still identified only by gross appearance and anatomical location during surgery, without
intraoperative image guidance. Near-infrared (NIR) fluorescent light, in the wavelength range of
650-900 nm, has the potential to provide high-resolution, high-sensitivity, and real-time avoidance
of nerve damage, but only if nerve-specific NIR fluorophores can be developed. In this study, we
evaluated a series of Oxazine derivatives to highlight various peripheral nerve structures in small
and large animals. Among the targeted fluorophores, Oxazine 4 has peak emission near into the
NIR, which provided nerve-targeted signal in the brachial plexus and sciatic nerve for up to 12 h
after a single intravenous injection. In addition, recurrent laryngeal nerves were successfully
identified and highlighted in real time in swine, which could be preserved during the course of
thyroid resection. Although optical properties of these agents are not yet optimal, chemical
structure analysis provides a basis for improving these prototype nerve-specific NIR fluorophores
even further.
Key words: Real-time intraoperative identification, nerve targeting, recurrent laryngeal nerve,
contrast agents, targeted agents, near-infrared imaging.

Introduction
Nerve damage during surgery results in significant morbidity and mortality [1-4]. Despite advancements in surgical technique and equipment, nerves
are currently identified via gross appearance and anatomical location, without intraoperative image
guidance. Thin or buried nerves are at high risk for
damage. Anatomical variants such as bifurcation, trifurcation, medial or anterior displacement, and

non-recurrence are also risk factors for injury [5,6].
For example, recurrent laryngeal nerve (RLN) injury
in the neck can cause symptoms ranging from
hoarseness and aspiration in unilateral injury, to life
threatening airway obstruction in the case of bilateral
injury [2,7]. To minimize such high morbidity and
mortality from nerve injury, intraoperative visual
identification during complex surgery is of parahttp://www.thno.org
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mount importance.
However, only 3 main classes of nerve-specific
molecules have been reported to date, including stilbene derivatives, distyrylbenzene (DSB) fluorophores,
and styryl pyridinium (FM) fluorophores [8-11].
Among these agents, DSBs such as BMB, GE3082, and
GE3111 have been investigated for image-guided
nerve surgery [12-14]. However, none of these compounds were optimal because of high adsorption and
scattering in tissues from the ultraviolet and visible
wavelengths required. In addition, due to their intrinsically high lipophilicity and charge, they exhibit
high background binding to adipose tissues, thus
lowering the signal-to-background ratio (SBR) considerably. Relatively high endogenous tissue autofluorescence in the visible wavelength range also limits the use of these fluorophores in vivo [15].
To overcome these limitations, nerve-specific
contrast agents in the near-infrared (NIR) range are
desperately needed. Recently, Whitney et al. synthesized peptides that localize to nerve-associated connective tissues [16]. They highlighted almost all
nerves in the body including motor and sensory
nerves, but only after labeling with exogenous fluorophores [16,17]. Gustafson et al. developed a NIR
fluorophore, which is hydrophilic indocyanine green
(ICG) analogue, for peripheral nerve targeting [18].
Gibbs et al. investigated the structure-activity relationship of over 200 nerve-specific contrast agents and
also screened these molecules for NIR optical properties. Although no NIR agents were obtained, several
putative fingerprints for nerve uptake were identified
[13]. Based on these results, we investigated Oxazine-based chemical structures for simultaneous
nerve uptake and NIR fluorescence. Our goal is to
develop nerve-specific agents in the NIR range [19],
which permits color video and NIR to be acquired
simultaneously, thus providing real time image-guidance to surgeons about nerve location.

Materials and Methods
Optical Property Measurements. Oxazine derivatives were obtained from Fisher Scientific Inc.
(Pittsburgh, PA) or Sigma-Aldrich (Saint Louis, MO),
and BMB was synthesized as described previously
[20]. Optical measurements were performed at 37°C
in phosphate-buffered saline (PBS), pH 7.4 or 100%
fetal bovine serum (FBS) buffered with 50 mM
HEPES, pH 7.4. Absorbance and fluorescence emission spectra were measured using fiber optic HR2000
absorbance (200–1100 nm) and USB2000FL fluorescence (350–1000 nm) spectrometers (Ocean Optics,
Dunedin, FL). A 532 nm green laser pointer (Opcom
Inc., Xiamen, China) set to 5 mW and coupled through
a 300 µm core diameter, NA 0.22 fiber (Fiberguide
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Industries, Stirling, NJ) was used to excite fluorophores and avoid spectral overlapping between the
laser excitation and fluorescence emission. In silico
calculation of the partition coefficient (logD at pH 7.4)
was calculated using Marvin and JChem calculator
plugins (ChemAxon, Budapest, Hungary). Chemical
similarities were calculated by Instant JChem 6.04
using “Chemical Hashed Fingerprint” with the Normalized Euclidean dissimilarity screening configuration (ChemAxon).
NIR Fluorescence Imaging System. The dual-NIR channel FLARE imaging system has been described in detail previously [21-23]. In this study, a 670
nm excitation was used at a fluence rate of 4 mW/cm2,
with white light (400–650 nm) at 40,000 lx. Color and
NIR fluorescence images were acquired simultaneously with custom software at rates up to 15 Hz over a
15 cm diameter field of view. A pseudo-colored lime
green was used for NIR fluorescence in the color-NIR
merged images. The imaging system was positioned
at a distance of 18 inches from the surgical field.
Ex Vivo Nerve-Specific Fluorophore Screening.
Sciatic nerves from female Yorkshire pigs were harvested, fixed in 2% paraformaldehyde (PFA), and
flash frozen in optimal cutting temperature (OCT)
compound using liquid nitrogen. Human sural nerve
tissue was provided by the Chonnam National University Medical School in a paraffin block, and swine
sciatic nerve was obtained from a Yorkshire pig prior
to injecting fluorophores. Nerve tissues were cut in
cross section using a cryostat at 10 μm thickness onto
positively charged glass slides. Tissue sections were
washed once with PBS for 2 min to remove residual
OCT. The tissue was then fixed to the slide with 2%
PFA for 15 min, followed by washing with PBS (3 x 5
min). A formulation was previously developed for
intravenous (IV) administration and was used in the
current study to incubate the fluorophores with the
nerve tissue [20]. All fluorophores were mixed from
the 100 mM stock solution into the IV formulation
(D5W containing 5% Cremophor EL) at 100 μM and
incubated with the washed nerve tissue sections at
room temperature for 20 min. Additional IV formulation not containing fluorophore was mixed and used
to wash each nerve section twice (5 min per wash)
following incubation with the formulated fluorophore. The nerve section was then washed an additional 2 times with PBS (5 min per each), after which
coverslips were mounted using Fluoromount-G
(Southern Biotech, Birmingham, AL).
NIR fluorescence microscopy for ex vivo nerve
tissue slides was performed on a Nikon Eclipse TE300
microscope system as previously described [12,20,24].
The microscope was equipped with a 100 W mercury
light source, NIR-compatible optics, and a
http://www.thno.org
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NIR-compatible 4X, 10x, and 20X Plan Fluor objective
lens (Nikon, Melville, NY). Images were acquired on
an Orca-AG (Hamamatsu, Bridgewater, NJ). Image
acquisition and analysis was performed using IPLab
software (Scanalytics, Fairfax, VA). A custom filter set
(Chroma Technology Corporation, Brattleboro, VT)
composed of a 650/44 nm excitation filter, a 675 nm
dichroic mirror, and a 710/50 nm emission filter were
used for 700 nm NIR imaging, while ET710/75x,
T760lpxr, and ET810/90m were used for 800 nm NIR
imaging. For BMB, a mercury light source was passed
through a 360/50 nm BP excitation filter, a 400 nm LP
beam splitter, and a 550/50 nm emission filter.
Animal Models. Animals were housed in an
AAALAC-certified facility. Animal studies were performed under the supervision of Beth Israel Deaconess Medical Center’s Institutional Animal Care and
Use Committee (IACUC) in accordance with approved institutional protocols (#101-2011 for rodents
and #046-2010 for pigs). Male CD-1 mice weighing ≈
25 g and Sprague-Dawley rats weighing ≈ 250 g
(Charles River Laboratories, Wilmington, MA) were
anesthetized with 100 mg/kg ketamine and 10 mg/kg
xylazine intraperitoneally (Webster Veterinary, Fort
Devens, MA). Female Yorkshire pigs (E.M. Parsons
and Sons, Hadley, MA) averaging 37 kg were induced
with 4.4 mg/kg intramuscular Telazol (Fort Dodge
Labs, Fort Dodge, IA), intubated, and maintained
with 2% isoflurane (Baxter Healthcare Corp., Deerfield, IL). Following anesthesia, electrocardiogram,
heart rate, pulse oximetry, and body temperature
were monitored throughout surgery. The number of
animals (N) used for each targeting and imaging experiment was 5.
Intraoperative Nerve-Targeting and Imaging.
For intravenous (IV) injection, each fluorophore was
dissolved in D5W containing 5% Cremophor EL at a 2
mM concentration. Initial in vivo screening occurred in
Sprague Dawley rats by injecting 1 µmol of each
fluorophore based on our previous study of BMB
(Supplementary Material: Supplementary Methods)
[20]. For kinetic and dose-response studies, 50 – 400
nmol of Oxazine 4 was injected intravenously into
CD-1 mice and measurements taken over 24 h (N = 5
per dose and time point). Control images were acquired prior to injecting NIR fluorophores. The fluorescence signal in nervous tissues and signal-to-background ratio (SBR) compared to neighboring muscle (Mu) was obtained over the period of
imaging. For the large animal study, the optimal dose
found in mice (200 – 400 nmol per mouse) was used in
pigs by scaling to body surface area [25,26]. 20 – 40
µmol (0.17 – 0.34 mg/kg) of Oxazine 4 was injected
intravenously into Yorkshire pigs and the fluores-
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cence images of recurrent laryngeal nerve (RLN),
brachial plexus (BP), and sciatic nerve (SN) were observed in real time using the FLARE imaging system
up to 4 h post-injection (N = 5 subjects).
Quantitation and Statistical Analysis. The fluorescence intensity (FI) and background (BG) intensity of a region of interest (ROI) over each
nerve/tissue were calculated and quantified using
custom FLARE software. The FI of the RLN, BP, and
SN at the optimal dose and time point were quantified
to measure tissue-specific targeting. Adjacent tissues
such as trachea (Tr), thyroid (Th), tracheoesophageal
groove (TEG), muscle (Mu), and adipose tissue (Ad)
were used as background to calculate the SBR of RLN,
BP, and SN in pigs. Statistical analysis was carried out
using a one-way ANOVA followed by Tukey’s multiple comparisons test. Results were presented as
mean ± S.D. and curve fitting was performed using
Prism version 4.0a software (GraphPad, San Diego,
CA).
Hematoxylin and Eosin (H&E) Histology and
Immunohistochemistry (IHC). RLN, BP, and SN
were extracted from rats and pigs 4 h post-injection
and placed in 2% paraformaldehyde for 30 min before
mounting in Tissue-Tek OCT compound (Fisher Scientific, Pittsburgh, PA) and flash-freezing in liquid
nitrogen. Frozen samples were cryosectioned (10 µm
per slice); 1 slide was stained with H&E and consecutive sections were used for fluorescence microscopy
and IHC. For IHC, rabbit anti-myelin basic protein
(MBP; #ab53294, Abchem) and goat anti-rabbit IRDye
800CW (#827-08365, Li-Cor) were used to visualize
myelin sheath. NIR fluorescence microscopy was
performed as described above for the ex vivo assay,
where Oxazine 4 and MBP antibody were imaged by
700 nm and 800 nm NIR channels, respectively.

Results
Chemical and Optical Properties. As shown in
Fig. 1, a series of symmetric Oxazine derivatives
having cationic pendant groups were explored for
nerve-specific targeting ex vivo and in vivo. BMB (ultraviolet excitation, visible emission) was used as a
positive control. Oxazine 1 and Oxazine 4 have relatively high extinction coefficients (> 140,000 M-1cm-1)
and a moderate Stokes shift (> 17 nm) in 100% serum,
pH 7.4 (Table 1 and Supplementary Material: Fig. S1).
The logD at pH 7.4 of BMB, Oxazine 170, and Oxazine
750 are higher than 3.5, while Oxazine 1 and Rhodamine 800 had values less than 1. The logD at pH 7.4 of
Oxazine 4 is 3.38 with a MW of 395.84 (Table 1 and
Supplementary Material: Fig. S1).

http://www.thno.org
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Figure 1. Chemical Structure of Nerve-Targeting Fluorophores. Oxazine 1 is also known as Oxazine 725.

Table 1. Chemical and Physical Properties of Nerve-Targeting Fluorophores.
Fluorophore

MW
(Da)

LogD,
pH 7.4

PSA
(Å2)

HBD/
HBA

Rotat.
Bonds

λ
(M-1cm-1)

Abs
(nm)

Em
(nm)

BMB
Oxazine 1
Oxazine 4
Oxazine 170
Oxazine 750
Rhodamine 800

364.06
423.89
395.84
431.87
469.92
495.95

4.84
0.33
3.38
3.94
4.67
0.43

61.27
27.84
47.59
47.59
38.80
39.27

2/3
0/3
2/3
2/3
1/3
0/3

5
5
3
3
1
0

52,800
196,000
143,000
69,000
44,000
68,000

397
655
616
625
676
697

498
670
635
650
684
710

Ex vivo
+
–
++
+
+
+

SBR
In vivo
+
–
+++
+
–
–

MW = molecular weight; PSA = polar surface area; HBD/HBA = H bond donors/acceptors; Rotat. Bonds = rotational bonds; λ = extinction coefficient; Abs = peak absorbance; Em = peak emission. The SBR of each nerve relative to the neighboring adipose tissue was quantified and labeled as –, < 1; +, 1 to 2; ++, 2 to 3; and +++, > 3.

Ex Vivo Nerve-Specific Fluorophores Screening. BMB, Oxazine 1, Oxazine 4, Oxazine 170, Oxazine
750, and Rhodamine 800 fluorophores were screened
for nerve-specific fluorescence and undesired adipose
uptake using cross sections of pig sciatic nerve (Supplementary Material: Fig. S2) and human sural nerve
tissue (Fig. 2a). Fluorescence images of Oxazine derivatives were compared with the previously identified nerve-specific fluorophore BMB (positive control). Oxazine 4, Oxazine 750, and Rhodamine 800
fluorophores exhibited strong fluorescence signal
throughout the cross-sectioned nerve fascicle, while
Oxazine 1 and 170 showed weak nerve-specific fluorescence signal. Although the positive control BMB
represented relatively high fluorescence in the nerve,
the signal in epineurium and adipose tissues was even
higher than the target signal (SBR < 1.0). From this ex
vivo nerve-specific screening Oxazine 4, Oxazine 750,
and Rhodamine 800 were identified as the potential
candidates for high performance in vivo.
In Vivo Nerve-Specific Fluorophores Screening. Initial screening of fluorophore performance in
vivo utilized a single intravenous injection of BMB and
Oxazine derivatives at a dose of 1 µmol in 250 g SD
rats 4 h prior to imaging (Fig. 2b). To compare the
difference between ex vivo and in vivo results, all
fluorophores used in ex vivo screening were examined

in vivo in the rat brachial plexus and sciatic nerve assays. Oxazine 4 showed the highest nerve-specific
fluorescence signal and the lowest background (muscle and adipose tissue) fluorescence signal compared
to other molecules and BMB. Although Oxazine 1
showed no nerve fluorescence by the ex vivo nerve
screening assay, it did have a weak signal in the vicinity of nerve, but could also have been caused by
high adipose tissue uptake. Based on these data, Oxazine 4 was chosen for further study.
Kinetics of Oxazine 4 Nerve Targeting in CD-1
Mice. To determine the time of peak SBR, we injected
100 nmol (1.6 mg/kg) of Oxazine 4 into mice and sacrificed N = 5 per time point. The fluorescence signal in
the BP and SN was bright enough by 1 h
post-injection, however, the SBR was low because of
high background signal from the salivary gland, adjacent muscle, adipose tissue, and skin. The highest
SBR ≈ 3.0 was achieved at 4 h post-intravenous injection, at which point surrounding background signal
had decreased significantly (*P < 0.05). Oxazine 4 uptake was higher in the brachial plexus compared to
sciatic nerve, of which signal retained up to 12 h. The
background signal completely diminished after 24 h
of a single IV injection, but the fluorescence signal in
nervous tissues also decayed over time (Fig. 3a).
http://www.thno.org
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Figure 2. Ex Vivo and In Vivo Screening Assay of Fluorophores for Nerve-Specificity. A) Nerve-specific fluorescence intensity was determined using staining of human sural nerve
cut in cross section and incubated with 100 µM of each fluorophore. Ep = epineurium; F = nerve fascicle. Scale bars = 200 µm. The partition coefficient (logD at pH 7.4) was
calculated using JChem calculator plugins. B) In vivo nerve-specific fluorescence in the rat brachial plexus (BP, top rows) and sciatic nerve (SN, bottom rows) 4 h post-injection.
Arrowheads indicate fluorescence signals in nerve tissue. SG = salivary gland. Scale bars = 1 cm. All NIR fluorescence images have identical exposure and normalizations.

http://www.thno.org

Theranostics 2014, Vol. 4, Issue 8

828

Figure 3. Kinetics and Dose-Response of Oxazine 4 Uptake in Mice. A) Quantitative time-course assessment of SBR (mean ± SEM) for brachial plexus (BP) and sciatic nerves
(SN). 100 nmol (1.6 mg/kg) of Oxazine was injected intravenously into CD-1 mice, and SBR (BP/Mu) and SBR (SN/Mu) were measured at different time points (T = 0, 1, 4, 6, 12,
and 24 h). Arrowheads indicate fluorescence signals in nerve bundles. SG = salivary glands; Mu = muscle. B) Dose-response curve of SBR (mean ± SEM) for BP and SN. 0, 50, 100,
200, and 400 nmol of Oxazine 4 were injected intravenously into CD-1 mice, and SBR (BP/Mu) and SBR (SN/Mu) were measured at 4 h post-injection. Arrowheads indicate
fluorescence signals in nerve bundles. Images are representative of N = 5 independent experiments. **P < 0.01 and *P < 0.05. SG = salivary glands; Mu = muscle. Scale bars = 1
cm. All NIR fluorescence images have identical exposure times (500 msec) and normalizations.

Dose-Dependence of Oxazine 4 Nerve Targeting in CD-1 Mice. Dose-dependent optimization was
investigated at 4 h post-injection. As shown in Fig. 3b,
the fluorescence signals in the BP and SN were proportional to the injected dose in the range of 50 – 400
nmol per mouse (0.8 – 6.3 mg/kg). The minimal dose
used to highlight peripheral nerves was 50 nmol,
however, a significant increase in nerve signals was
found when injected with 200 nmol of Oxazine 4 (**P
< 0.01 for BP and *P < 0.05 for SN). Although the
maximum nerve signal was obtained with the IV injection of 400 nmol Oxazine 4, the background signals
in the surrounding muscle and adipose tissues were
significantly increased as well. Therefore, no significant differences were observed in the SBR of BP and
SN between the dose of 200 nmol and 400 nmol (P >
0.05).
Optimal Nerve Targeting Using Oxazine 4 in
SD Rats. The BP and SN were clearly identified and
highlighted after a single intravenous injection of
Oxazine 4 in CD-1 mice. However, branched peripheral nerves are not identified because of difficulty in
visual identification. To find out branched nerves in
small animals, we injected 1 µmol of Oxazine 4 intravenously into SD rats 4 h prior to imaging based on
the optimized condition in Fig. 3. As indicated by
arrowheads, small branches of main nerves including
BP and SN could be identified in the fluorescence

images that could not be distinguished visually using
color video (Fig. 4a). In addition, the nervous structure was confirmed by IHC using an anti-myelin basic
protein (MBP) antibody. MBP is a major component of
multilayered myelin sheath and interact with the lipids in the myelin membrane [14,27]. As shown in
Fig. 4b, Oxazine 4 colocalizes with the myelinated
sheath within the fascicle, which was stained by the
MBP antibody.
Oxazine 4 Nerve Targeting in Large Animals.
Various sites of important peripheral nerves were
surgically exposed and imaged with Channel 1 (≈ 700
nm) of the FLARE imaging system at 5, 15, 30, 60, 120,
180, and 240 min post-injection (Fig. 5). In the
pre-injection images, RLN, BP, and SN show almost
no autofluorescence, however, thyroid (Th) shows
relatively high autofluorescence. Since the RLN is
usually located in the tracheoesophageal groove
(TEG), the SBR between nerves and adjacent tissues
such as trachea, TEG, and Th is the key determinant
for preserving the RLN during surgery. The fluorescence signal in the RLN was relatively high by 30 min
post-injection, however, excessive signals remained in
the surrounding tissues. Therefore, the maximal SBR
was achieved 3 h post-injection (Fig. 5a). This time
span should be enough to identify thin and buried
RLNs and avoid nerve damage during thyroidectomy
in real time. On the other hand, BP and SN were relahttp://www.thno.org
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tively easily identified at early time points, and the
maximal SBR for BP and SN was achieved at 1 h and 2
h post-injection, respectively. As shown in Fig. 5b, the
signals in nervous tissue retained up to 4 h
post-injection. In order to see the reliability of intraoperative RLN mapping for thyroid patients who
get reoperation after thyroidectomy, we removed
thyroid and observed RLN and surrounding tissues
(Fig. 5b). The absence of thyroid improved the identification of RLN in real time, and the SBR of RLN with
neighboring tissue was higher than 1.0. Additionally,
nerves were resected and cryosectioned for H&E and
fluorescence microscopy. As shown in Fig. 5c, NIR
fluorescence microscopic images confirm bright fluorescence signal throughout the nerve, which indicates
the entire endoneurium surrounding individual axon
and myelinated fibers within the fascicle could be
stained by the single intravenous injection of Oxazine 4.

829
Quantitative Structure-Activity Relationships
(QSAR). Based on the QSAR screening and chemical
group fingerprinting of BMB [13], we compared the 5
positive fingerprints with our new nerve-targeting
fluorophores. Among the series, Oxazine 4 met the
basic requirement of a balanced para configuration of
the core (Supplementary Material: Fig. S4; [13]). In
addition, Oxazine 4 showed the highest similarity
with the 5 highest ranked fingerprints except for BMB.
As shown in Fig. 6, when compared to the chemical
structure of BMB and its constituent groups, Oxazine
4 also ranked top in most cases. Rhodamine 800
scored higher for some fragments, but its uptake in
nerve was low because of its low logD at pH 7.4 (0.43).
Conversely, Oxazine 170 and Oxazine 750, which
have high logD at pH 7.4 values (3.94 and 4.67, respectively) showed strong adipose uptake both ex vivo
and in vivo.

Figure 4. In Vivo Nerve-Specific Targeting using Oxazine 4 in Rats. A) 1 µmol of Oxazine 4 was injected intravenously into SD rats 4 h prior to imaging. Shown are color image,
NIR fluorescence, a merged image of the two (pseudo-colored in lime green), and magnified images of NIR fluorescence acquired using the FLARE imaging system. Arrowheads
indicate small branches of main nerves, which cannot be seen in color image. Scale bars = 1 cm. B) H&E, phase image, NIR fluorescence (Oxazine 4, 700 nm NIR), and immunostaining (right) of small branched peripheral nerves obtained from A using an anti-myelin antibody conjugated with IRDye 800CW. Squares on low-resolution images
indicate the positions of magnified images. Pseudo-colored red and green colors were used for 700 nm and 800 nm channel images, respectively. Scale bars = 100 µm. Images are
representative of N = 5 independent experiments. All NIR fluorescence images have identical exposure and normalizations.

http://www.thno.org

Theranostics 2014, Vol. 4, Issue 8

830

Figure 5. Kinetics of Oxazine 4 Uptake in Pig Nerves. A) Quantitative time course assessment of SBR (mean ± SEM) for recurrent laryngeal nerve (RLN), brachial plexus (BP),
and sciatic nerve (SN). 20 µmol (0.25 mg/kg) of Oxazine 4 was injected intravenously into 35 kg Yorkshire pigs, and the SBR of nerves to the specified surrounding tissue was
measured at different time points (T = 0, 15, 30, 60, 120, 180, and 240 min). B) Real-time intraoperative fluorescence images of RLN (top), BP (middle), and SN (bottom) acquired
at different time points (T = 0, 1, 2, and 4 h). Thyroid was resected (thyroidectomy) after 4 h, and RLN was highlighted without signal interruption. Ad = adipose tissue; Mu =
muscle; TEG = tracheoesophageal groove; Th = thyroid; Tr = trachea. Scale bars = 1 cm. C) Fluorescence microscopic images of cryosectioned RLN, BP, and SN. Samples were
obtained after injecting 20 µmol of Oxazine 4 into Yorkshire pigs 4 h prior to resection. Shown are representative images (N = 5) of H&E (left) and NIR fluorescence (right)
images. Blue squares on H&E images indicate the positions of magnified images. Scale bars = 100 µm. All NIR fluorescence images have identical exposure times and normalizations.

http://www.thno.org
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Figure 6. Chemical Similarities between Non-NIR and NIR Nerve-Specific Contrast Agents. BMB (non-NIR) and Oxazine 4 (NIR) are shown as 2D energy-minimized structures,
3D structures with charge (red = negative; blue = positive) and hydrophobicity (gray) distributions, and in comparison to BMB and its sub-structures. Similarity was calculated
using the chemical hashed fingerprint method with a Normalized Euclidean screening configuration (Instant JChem v 6.04, ChemAxon).

Discussion
Image-guided surgery is now in routine clinical
use to improve surgical fields by using interventional
MRI, ultrasound, and electrophysiological recordings.
However, limitations remain in regard to visualizing
and guiding thin or buried nerves due to the lack of
nerve-specific imaging [28]. Most recently, Tsien and
colleagues made a significant improvement in
nerve-specific targeting and imaging, where an engineered peptide FAM-NP41 was used to label in vivo
animal nerves and resected human RLN with relatively high affinity [16]. Since small molecules are
about 10-1000 fold smaller than peptides and proteins,
however, they will need at least 10-fold less dosage if
the affinity is identical. It should be noted that the

optimal dose of the molecules we describe in this
study is 10-50 fold lower than previously described
nerve-specific fluorophores [11-13,16] and corresponds to a human equivalent dose of only 0.25
mg/kg [25,26], which is consistent with the clinically-approved dose of the NIR fluorophore indocyanine
green (ICG). Importantly, at this dose range, Oxazine
4 does not stain the central nervous system, and did
not show apparent impairment of motor function and
sensory integrity during the 24 h post-injection (data
not shown).
Furthermore, the modification of physicochemical properties of small molecules is relatively easy for
real-time image guided surgery [29]. To develop an
ideal nerve-specific contrast agent for image-guided
surgery, we need to consider the following criteria: 1)
http://www.thno.org
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logD at pH 7.4 between 0.5 to 3 and molecular weight
< 500 Da to maximize blood-nerve-barrier (BNB)
penetration, 2) excitation and emission wavelengths
in the NIR window, and 3) prolonged retention in the
nerve tissue [30]. To the best of our knowledge, Oxazine 4 is the first small molecule described to date that
closely meets all criteria. Based on its chemical similarity to BMB, Oxazine 4 likely targets myelin or a
closely associated molecule. Nonetheless, it should be
considered a prototype molecule because the optical
property of Oxazine 4 is not in the true NIR window.
Additionally, biodistribution and clearance should be
considered because they mediate the fate of contrast
agents in vivo such as how long after intravenous injection a contrast agent reaches peak SBR, and how
long the signal lasts. The nerve-specific signals may
vary depending on the species because of different
biodistribution, metabolism, and pharmacokinetics.
However, the pharmacokinetic data presented in both
small and large animals suggest that nerve penetration is rapid, blood and tissue clearance is rapid, yet
retention in nerves is strong enough to permit an SBR
> 1 for 3-4 hours, which is good enough for complicated nerve surgery. After optimizing the optical and
chemical properties described above, attention will
need to be turned to nerve affinity. Increasing affinity
will further improve nerve retention while also increasing signal strength and the imaging period.
In
summary,
near-infrared
fluorescent,
nerve-specific small molecules could be considered
the Holy Grail in the field of image-guided surgery.
Although our work does not conclude the quest, it
lays the foundation for another push towards the goal
by helping surgeons to avoid nerve damage on a patient-specific basis.

Supplementary Material
Supplementary methods, Fig.S1 - Fig.S5.
http://www.thno.org/v04p0823s1.pdf
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